Position in XENE
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$8,184,903
-$7,439,573 QoQ
Shares Held
140,755
-59.6% QoQ
Ownership
0.146%
of shares outstanding
% of Portfolio
1.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 88.94035735853078.ToString("F0")%
Shared 0.ToString("F0")%
None 11.05964264146922.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026STEMPOINT CAPITAL LP holds $493,288,963 across 62 Biotechnology names. XENE ranks #22 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SRRK |
Scholar Rock Holding Corp
|
1,035,496 | $50,904,983 | |
| 2 | ABVX |
Abivax S.A.
|
313,791 | $34,940,627 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
1,215,743 | $28,399,756 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
281,632 | $27,388,712 | |
| 5 | IMVT |
Immunovant, Inc.
|
746,494 | $18,542,910 | |
| 6 | PRAX |
Praxis Precision Medicines, Inc.
|
56,267 | $18,128,664 | |
| 7 | SRZN |
Surrozen, Inc./DE
|
525,639 | $15,311,863 | |
| 8 | MBX |
MBX Biosciences, Inc.
|
499,469 | $14,909,149 |
All Filings in XENE
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,184,903 | 140,755 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $15,624,476 | 348,605 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,720,644 | 192,295 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $9,213,937 | 274,633 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,733,124 | 375,845 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||